Operating Expenses Summary of Sanofi

Sanofi's latest annual operating expenses in 2023 was 23.94 Billion EUR , down -12.61% from previous year.
Sanofi's latest quarterly operating expenses in 2024 Q2 was 8.89 Billion EUR , up 5.78% from previous quarter.
Sanofi reported a annual operating expenses of 19.81 Billion EUR in annual operating expenses 2022, up 11.48% from previous year.
Sanofi reported a annual operating expenses of 17.77 Billion EUR in annual operating expenses 2021, up 2.62% from previous year.
Sanofi reported a quarterly operating expenses of 8.89 Billion EUR for 2024 Q2, up 5.78% from previous quarter.
Sanofi reported a quarterly operating expenses of 9.04 Billion EUR for 2023 Q4, up 67.44% from previous quarter.

Annual Operating Expenses Chart of Sanofi (2023 - 1999)

Historical Annual Operating Expenses of Sanofi (2023 - 1999)

Year	Operating Expenses	Operating Expenses Growth
2023	23.94 Billion EUR	-12.61%
2022	19.81 Billion EUR	11.48%
2021	17.77 Billion EUR	2.62%
2020	17.32 Billion EUR	-6.25%
2019	18.47 Billion EUR	2.71%
2018	17.98 Billion EUR	3.34%
2017	17.4 Billion EUR	5.69%
2016	16.46 Billion EUR	-2.02%
2015	16.8 Billion EUR	11.84%
2014	15.02 Billion EUR	2.72%
2013	14.63 Billion EUR	-13.83%
2012	16.97 Billion EUR	2.51%
2011	16.56 Billion EUR	2.58%
2010	16.14 Billion EUR	4.7%
2009	15.42 Billion EUR	3.18%
2008	14.94 Billion EUR	-3.75%
2007	15.53 Billion EUR	-2.32%
2006	15.89 Billion EUR	4.52%
2005	15.21 Billion EUR	97.3%
2004	7.7 Billion EUR	117.84%
2003	3.53 Billion EUR	2.3%
2002	3.45 Billion EUR	10.56%
2001	3.12 Billion EUR	6.28%
2000	2.94 Billion EUR	6.17%
1999	2.77 Billion EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	5.44 Billion EUR	-30.71%
2024 Q2	8.89 Billion EUR	5.78%
2023 Q4	9.04 Billion EUR	67.44%
2023 Q2	5.25 Billion EUR	5.82%
2023 Q3	5.4 Billion EUR	2.86%
2023 Q1	4.96 Billion EUR	-7.32%
2023 FY	17.31 Billion EUR	-12.61%
2022 FY	19.81 Billion EUR	11.48%
2022 Q3	4.66 Billion EUR	-10.66%
2022 Q1	4.58 Billion EUR	-10.53%
2022 Q2	5.21 Billion EUR	13.84%
2022 Q4	5.35 Billion EUR	14.91%
2021 Q2	4.31 Billion EUR	9.32%
2021 Q3	4.38 Billion EUR	1.55%
2021 Q4	5.12 Billion EUR	16.78%
2021 FY	17.77 Billion EUR	2.62%
2021 Q1	3.95 Billion EUR	-14.8%
2020 Q4	4.63 Billion EUR	10.96%
2020 Q1	4.38 Billion EUR	-12.33%
2020 FY	17.32 Billion EUR	-6.25%
2020 Q3	4.17 Billion EUR	-0.71%
2020 Q2	4.2 Billion EUR	-4.06%
2019 Q3	4.31 Billion EUR	-8.22%
2019 Q2	4.69 Billion EUR	6.24%
2019 Q1	4.42 Billion EUR	-14.84%
2019 Q4	5 Billion EUR	16.08%
2019 FY	18.47 Billion EUR	2.71%
2018 Q3	4.38 Billion EUR	1.11%
2018 Q4	5.19 Billion EUR	18.44%
2018 FY	17.98 Billion EUR	3.34%
2018 Q1	4.08 Billion EUR	-13.5%
2018 Q2	4.33 Billion EUR	6.2%
2017 FY	17.4 Billion EUR	5.69%
2017 Q3	4.07 Billion EUR	-6.26%
2017 Q2	4.34 Billion EUR	2.09%
2017 Q1	4.25 Billion EUR	-6.05%
2017 Q4	4.71 Billion EUR	15.84%
2016 FY	16.46 Billion EUR	-2.02%
2016 Q1	3.79 Billion EUR	12.77%
2016 Q4	4.53 Billion EUR	12.77%
2016 Q3	4.01 Billion EUR	-2.78%
2016 Q2	4.13 Billion EUR	8.79%
2015 Q1	3.97 Billion EUR	-8.41%
2015 Q3	4.55 Billion EUR	9.27%
2015 Q2	4.16 Billion EUR	4.75%
2015 Q4	3.36 Billion EUR	-25.98%
2015 FY	16.8 Billion EUR	11.84%
2014 Q4	4.34 Billion EUR	9.13%
2014 FY	15.02 Billion EUR	2.72%
2014 Q3	3.97 Billion EUR	-0.9%
2014 Q2	4.01 Billion EUR	2.4%
2014 Q1	3.91 Billion EUR	2.46%
2013 FY	14.63 Billion EUR	-13.83%
2013 Q4	3.82 Billion EUR	-0.78%
2013 Q3	3.85 Billion EUR	-6.39%
2013 Q2	4.11 Billion EUR	1.86%
2013 Q1	4.04 Billion EUR	-4.78%
2012 Q2	4.5 Billion EUR	13.6%
2012 Q4	4.24 Billion EUR	4.58%
2012 Q1	3.96 Billion EUR	-8.75%
2012 Q3	4.06 Billion EUR	-9.84%
2012 FY	16.97 Billion EUR	2.51%
2011 Q2	4.41 Billion EUR	13.95%
2011 Q1	3.87 Billion EUR	-16.82%
2011 Q3	3.87 Billion EUR	-12.2%
2011 Q4	4.34 Billion EUR	12.16%
2011 FY	16.56 Billion EUR	2.58%
2010 Q3	3.77 Billion EUR	-4.79%
2010 Q1	3.58 Billion EUR	-11.08%
2010 FY	16.14 Billion EUR	4.7%
2010 Q4	4.65 Billion EUR	23.25%
2010 Q2	3.96 Billion EUR	10.5%
2009 Q1	3.63 Billion EUR	-49.02%
2009 Q2	3.78 Billion EUR	4.19%
2009 Q3	3.6 Billion EUR	-4.73%
2009 FY	15.42 Billion EUR	3.18%
2009 Q4	4.03 Billion EUR	12.02%
2008 Q2	3.7 Billion EUR	27.24%
2008 Q3	2.73 Billion EUR	-26.32%
2008 Q1	2.91 Billion EUR	112.56%
2008 FY	14.94 Billion EUR	-3.75%
2008 Q4	7.12 Billion EUR	160.65%
2007 Q2	3.81 Billion EUR	0.0%
2007 Q1	- EUR	100.0%
2007 Q3	- EUR	-100.0%
2007 Q4	-23.19 Billion EUR	0.0%
2007 FY	15.53 Billion EUR	-2.32%
2006 Q4	-23.48 Billion EUR	0.0%
2006 Q2	4.45 Billion EUR	117.73%
2006 FY	15.89 Billion EUR	4.52%
2006 Q3	- EUR	-100.0%
2006 Q1	2.04 Billion EUR	-78.19%
2005 Q4	9.37 Billion EUR	377.54%
2005 Q3	1.96 Billion EUR	-44.67%
2005 Q1	949.63 Million EUR	106.19%
2005 Q2	3.54 Billion EUR	273.81%
2005 FY	15.21 Billion EUR	97.3%
2004 Q3	- EUR	-100.0%
2004 Q4	-15.33 Billion EUR	0.0%
2004 FY	7.7 Billion EUR	117.84%
2004 Q2	1.06 Billion EUR	0.0%
2004 Q1	- EUR	100.0%
2003 FY	3.53 Billion EUR	2.3%
2003 Q2	878.67 Million EUR	0.0%
2003 Q1	- EUR	100.0%
2003 Q4	-4.96 Billion EUR	0.0%
2003 Q3	- EUR	-100.0%
2002 Q3	- EUR	-100.0%
2002 Q4	-4.83 Billion EUR	0.0%
2002 FY	3.45 Billion EUR	10.56%
2002 Q2	869.7 Million EUR	0.0%
2001 FY	3.12 Billion EUR	6.28%
2000 FY	2.94 Billion EUR	6.17%
1999 FY	2.77 Billion EUR	0.0%

Peer Operating Expenses Comparison of Sanofi

Name	Operating Expenses	Operating Expenses Difference
Amgen Inc.	11.87 Billion USD	-101.566%
AstraZeneca PLC	29.57 Billion USD	19.055%
Biogen Inc.	5.2 Billion USD	-359.99%
Gilead Sciences, Inc.	13.01 Billion USD	-83.985%
MIRA Pharmaceuticals, Inc.	8.52 Million USD	-280709.988%
Scilex Holding Company	136.49 Million USD	-17440.826%
Scilex Holding Company	136.49 Million USD	-17440.826%

Global Stocks Search

Sanofi (SNY)

Operating Expenses Summary of Sanofi

Annual Operating Expenses Chart of Sanofi (2023 - 1999)

Historical Annual Operating Expenses of Sanofi (2023 - 1999)

Peer Operating Expenses Comparison of Sanofi